You can buy or sell MOTS and other stocks, options, ETFs, and crypto commission-free!
Motus GI Holdings, Inc. Common Stock, also called Motus GI Holdings, is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. Read More It engages in the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company was founded in September, 2016 and is headquartered in Fort Lauderdale, FL.
Fort Lauderdale, Florida
52 Week High
52 Week Low
Yahoo FinanceMay 10
Motus GI Reports First Quarter 2019 Financial Results and Provides Corporate Update
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- – Full clinical results of REDUCE Study to be presented at Digestive Disease Week® 2019 –Pure-Vu® System GEN2 Special 510(k) Notice to FDA Submitted – Commercial launch of Pure-Vu® System GEN2 in the U.S. hospital market on track for 2019 Motus GI Holdings, Inc., (MOTS) ("Motus GI" or the "Company"), a medical technology company dedicated to improving clinical outcomes and enhancing the cost-efficiency of colonoscopy, today reported its financial results for the ...
Simply Wall StApr 26
How Many Motus GI Holdings, Inc. (NASDAQ:MOTS) Shares Did Insiders Buy, In The Last Year?
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So shareholders might well want to know whether insiders have been buying or selling shares in Motus GI Holdings, Inc. (NASDAQ:MOTS). What Is Insider Buying? It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, most countries require tha...
-$0.29 per share
-$0.29 per share